Risk factors and prognosis of interstitial lung disease for primary Sjögren syndrome patients: A retrospective case‒control study

被引：0
|
作者：
Yichen Huang
Yanran Qiu
Zhijun Xie
Fengqi Zhang
Yi Zhang
Meihui Guan
Xinchang Wang
Wanru Cai
Jing Sun
机构：
[1] The Second Clinical College,School of Basic Medical Science
[2] Zhejiang Chinese Medical University,undefined
[3] Zhejiang Chinese Medical University,undefined
来源：
Clinical Rheumatology | 2023年 / 42卷
关键词：
Case‒control study; Interstitial lung disease; Primary Sjögren syndrome; Risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3033 / 3041
页数：8
相关论文
共 50 条
  • [21] Risk factors for the recurrence of interstitial lung disease in patients with polymyositis and dermatomyositis: a retrospective cohort study
    Maho Nakazawa
    Yuko Kaneko
    Tsutomu Takeuchi
    Clinical Rheumatology, 2018, 37 : 765 - 771
  • [22] Risk factors for primary Sjögren’s Syndrome: a systematic review and meta-analysis
    Liang Jin
    Min Dai
    Chengyin Li
    Jing Wang
    Bin Wu
    Clinical Rheumatology, 2023, 42 : 327 - 338
  • [23] Risk factors for the recurrence of interstitial lung disease in patients with polymyositis and dermatomyositis: a retrospective cohort study
    Nakazawa, Maho
    Kaneko, Yuko
    Takeuchi, Tsutomu
    CLINICAL RHEUMATOLOGY, 2018, 37 (03) : 765 - 771
  • [24] Clinical features and risk factors of Raynaud’s phenomenon in primary Sjögren’s syndrome
    Wei Lin
    Zhifei Xin
    Xiaoran Ning
    Yang Li
    Xiuying Ren
    Yashuang Su
    Meilu Liu
    Shaoying Guo
    Liu Yang
    Yixuan Liu
    Fengxiao Zhang
    Wen Zhang
    Clinical Rheumatology, 2021, 40 : 4081 - 4087
  • [25] Risk factors for progression and prognosis of primary Sjogren's syndrome-associated interstitial lung disease in a Chinese population
    Xu, Yuetong
    Zhou, Junfei
    Dong, Xin
    Guo, Xiaojuan
    Lu, Yuewu
    Zheng, Yi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (12) : 1734 - 1740
  • [26] Prevalence and risk factors of interstitial lung disease in patients with primary Sjogren's syndrome: A systematic review and meta-analysis
    He, Chengmei
    Chen, Zhilei
    Liu, Suying
    Chen, Hua
    Zhang, Fengchun
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (08) : 1009 - 1018
  • [27] KL-6 as a Biomarker of Interstitial Lung Disease Development in Patients with Sjogren Syndrome: A Retrospective Case-Control Study
    Chiu, Yu-Hsiang
    Chu, Chen-Chih
    Lu, Chun-Chi
    Liu, Feng-Cheng
    Tang, Shin-En
    Chu, Shi-Jye
    Kuo, San-Yuan
    Chen, Hsiang-Cheng
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 2255 - 2262
  • [28] Risk factors for progression of interstitial lung disease in Sjogren's syndrome: a single-centered, retrospective study
    He, Shi-Hao
    He, Yu-Jie
    Guo, Kuang-Jin
    Liang, Xu
    Li, Shan-Shan
    Li, Tian-Fang
    CLINICAL RHEUMATOLOGY, 2022, 41 (04) : 1153 - 1161
  • [29] Tofacitinib in the treatment of primary Sjögren's syndrome-associated interstitial lung disease: study protocol for a prospective, randomized, controlled and open-label trial
    Gao, Ronglin
    Pu, Jincheng
    Wang, Yanqing
    Wu, Zhenzhen
    Liang, Yuanyuan
    Song, Jiamin
    Pan, Shengnan
    Han, Fang
    Yang, Lufei
    Xu, Xianghuai
    Tang, Jianping
    Wang, Xuan
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [30] Tofacitinib in the treatment of primary Sjögren’s syndrome-associated interstitial lung disease: study protocol for a prospective, randomized, controlled and open-label trial
    Ronglin Gao
    Jincheng Pu
    Yanqing Wang
    Zhenzhen Wu
    Yuanyuan Liang
    Jiamin Song
    Shengnan Pan
    Fang Han
    Lufei Yang
    Xianghuai Xu
    Jianping Tang
    Xuan Wang
    BMC Pulmonary Medicine, 23
12345